What is Jushi Holdings Inc.'s (JUSH.CN) StockRank?

MoatMap's StockRank for Jushi Holdings Inc. (JUSH.CN) is 25/100, with a Sell signal. This is a composite score combining Quality (39), Value (44), and Momentum (31) factor ranks across MoatMap's 20,000+ stock universe.

Does Jushi Holdings Inc. have an economic moat?

Jushi Holdings Inc. (JUSH.CN) has a Quality factor score of 39/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Jushi Holdings Inc. a buy, hold, or sell?

MoatMap's current signal for Jushi Holdings Inc. (JUSH.CN) is Sell, based on a StockRank of 25/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Jushi Holdings Inc. in?

Jushi Holdings Inc. (JUSH.CN) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (United States).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

JUSH.CN

SELLREMOVE

Jushi Holdings Inc. · Healthcare · United States · $93M · Avg Vol: $38K/d

StockRank

P/E (TTM)

—

ROE

—

D/E

—

Dividend %

—

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Jushi Holdings is a micro-cap cannabis operator with weak quality metrics and high regulatory uncertainty, failing our quality compounder lens.

COMPANY DESCRIPTION

Jushi Holdings Inc. is a vertically integrated multi-state cannabis operator (MSO) in the United States, focusing on retail, branding, cultivation, and processing. The company builds a competitive moat by targeting high-barrier, limited-license states such as Pennsylvania, Virginia, and Ohio. Jushi's strategic retail footprint, operating under the BEYOND / HELLO brand, drives stable cash flows and strong regional market share.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR
Revenue	200.6M	190.2M	181.7M	185.5M	-2.6%
EPS	-0.75	-0.23	-0.18	-0.25	—
Shares	196.7M	196.6M	196.7M	199.7M	+1.5%
Debt	226.7M	210.9M	191.3M	207.1M	-3.0%
Equity	33.4M	-4.4M	-35.5M	-81.4M	—
Op CF	-15.1M	-2.3M	15.2M	12.5M	-17.8%
Inv CF	-57.1M	-4.5M	-5.0M	-9.3M	—
Fin CF	24.0M	9.8M	-17.3M	0.5M	—

PRICE (1Y)-7.4%

SMA 50SMA 200

$0.44

RSI (14)

37.0

52W High

$0.94

From 52W High

0.5%

SCORE BREAKDOWN

Quality

ROIC

2.2%48.9

ROE

—N/A

GP/Assets

38.1%77.2

Op. Margin

2.4%49.3

FCF/Assets

-1.1%46.6

Piotroski

316.1

Int. Cover

0.2x36.7

D/E Ratio

—N/A

Current Ratio

1.13x14.1

Value

P/E (TTM)

—N/A

EV/EBITDA

7.3x82.3

P/FCF

—N/A

P/B

-0.5x25.0

P/S

0.4x95.5

Div Yield

—N/A

Momentum

52W High %

47%24.0

RS 6M

-26%20.8

SMA 50/200

0.89x32.0

EPS Rev 4W

+2.0%87.0

EPS Rev 12W

—N/A

EPS Improve

+56%57.0

Q Growth

—N/A

FUNDAMENTALS

Market Cap

$93M

P/E (Forward)

-3.1x

Gross Margin

44.5%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of JUSH.CN are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
JUSH.CN	Jushi Holdings Inc.(you)	$93M	25	SELL
CWEB.TO	Charlotte's Web Holdings, Inc.	$74M	30	SELL
SCYX	SCYNEXIS, Inc.	$58M	34	SELL
DERM	Journey Medical Corporation	$180M	19	STRONG SELL
TKNO	Alpha Teknova, Inc.	$272M	32	SELL
CL.CN	Cresco Labs Inc.	$293M	31	SELL
ORGO	Organogenesis Holdings Inc.	$309M	31	SELL
AKBA	Akebia Therapeutics, Inc.	$299M	18	STRONG SELL
CTOR	Citius Oncology, Inc.	$65M	2	STRONG SELL
LFCR	Lifecore Biomedical, Inc.	$207M	10	STRONG SELL

Peer medians: ROE -23.5% · P/E 25.2x · Gross margin 44.3%

Jushi Holdings Inc. (JUSH.CN) — Stock Score Summary

Jushi Holdings Inc. (JUSH.CN) has a MoatMap StockRank of 25/100 based on Quality (39/100), Value (44/100), and Momentum (31/100) factor scores. The current signal is SELL. Jushi Holdings is a micro-cap cannabis operator with weak quality metrics and high regulatory uncertainty, failing our quality compounder lens.

Key Financial Metrics

Price	$0.44
Market Cap	$93M
P/E (Forward)	-3.06
Price/Book	-0.51
Return on Invested Capital	2.2%
Gross Margin	44.5%
Operating Margin	2.4%
Revenue Growth	4.1%
Free Cash Flow	$-2M

Jushi Holdings Inc. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Jushi Holdings Inc.’s (JUSH.CN) StockRank?: MoatMap’s StockRank for Jushi Holdings Inc. (JUSH.CN) is 25/100, with a Sell signal. It is a composite of Quality (39), Value (44), and Momentum (31) factor ranks across MoatMap’s 20,000+ stock universe.
Does Jushi Holdings Inc. have an economic moat?: Jushi Holdings Inc. (JUSH.CN) has a Quality factor score of 39/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Jushi Holdings Inc. a buy, hold, or sell?: MoatMap’s current signal for Jushi Holdings Inc. (JUSH.CN) is Sell, based on a StockRank of 25/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Jushi Holdings Inc. in?: Jushi Holdings Inc. (JUSH.CN) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (United States).